{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:44:43Z","timestamp":1788324283111,"version":"build-2803163510"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-025-02209-y","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T10:02:01Z","timestamp":1766138521000},"page":"67-80","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Plasmodium-derived nanoparticle vaccine elicits sterile protection against malaria in mice"],"prefix":"10.1038","volume":"11","author":[{"given":"Dashuang","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5773-5372","authenticated-orcid":false,"given":"Thayne H.","family":"Dickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6718-8664","authenticated-orcid":false,"given":"Palak N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichole D.","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Kwan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaysies","family":"Queen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myesha","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Delbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Conteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn E.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4483-5005","authenticated-orcid":false,"given":"Patrick E.","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2689-1337","authenticated-orcid":false,"given":"Niraj H.","family":"Tolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"2209_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00330-7","volume":"6","author":"B Nguyen","year":"2021","unstructured":"Nguyen, B. & Tolia, N. H. Protein-based antigen presentation platforms for nanoparticle vaccines. NPJ Vaccines 6, 70 (2021).","journal-title":"NPJ Vaccines"},{"key":"2209_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","volume":"11","author":"R Noad","year":"2003","unstructured":"Noad, R. & Roy, P. Virus-like particles as immunogens. Trends Microbiol. 11, 438\u2013444 (2003).","journal-title":"Trends Microbiol."},{"key":"2209_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1586\/14760584.6.3.381","volume":"6","author":"B Chackerian","year":"2007","unstructured":"Chackerian, B. Virus-like particles: flexible platforms for vaccine development. Expert Rev. Vaccines 6, 381\u2013390 (2007).","journal-title":"Expert Rev. Vaccines"},{"key":"2209_CR4","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1586\/erv.10.115","volume":"9","author":"A Roldao","year":"2010","unstructured":"Roldao, A., Mellado, M. C., Castilho, L. R., Carrondo, M. J. & Alves, P. M. Virus-like particles in vaccine development. Expert Rev. Vaccines 9, 1149\u20131176 (2010).","journal-title":"Expert Rev. Vaccines"},{"key":"2209_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","volume":"31","author":"N Kushnir","year":"2012","unstructured":"Kushnir, N., Streatfield, S. J. & Yusibov, V. Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 31, 58\u201383 (2012).","journal-title":"Vaccine"},{"key":"2209_CR6","doi-asserted-by":"publisher","first-page":"e9809","DOI":"10.1371\/journal.pone.0009809","volume":"5","author":"AC Tissot","year":"2010","unstructured":"Tissot, A. C. et al. Versatile virus-like particle carrier for epitope based vaccines. PLoS ONE 5, e9809 (2010).","journal-title":"PLoS ONE"},{"key":"2209_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1574-1","volume":"15","author":"CM Janitzek","year":"2016","unstructured":"Janitzek, C. M. et al. Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses. Malar. J. 15, 545 (2016).","journal-title":"Malar. J."},{"key":"2209_CR8","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1016\/j.vaccine.2017.05.054","volume":"35","author":"SK Singh","year":"2017","unstructured":"Singh, S. K. et al. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48\/45 based vaccine antigen by SpyTag\/SpyCatcher mediated virus-like display. Vaccine 35, 3726\u20133732 (2017).","journal-title":"Vaccine"},{"key":"2209_CR9","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/nbt1197-1280","volume":"15","author":"SC Gilbert","year":"1997","unstructured":"Gilbert, S. C. et al. A protein particle vaccine containing multiple malaria epitopes. Nat. Biotechnol. 15, 1280\u20131284 (1997).","journal-title":"Nat. Biotechnol."},{"key":"2209_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/0264-410X(94)00038-O","volume":"13","author":"R Schirmbeck","year":"1995","unstructured":"Schirmbeck, R. et al. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens. Vaccine 13, 857\u2013865 (1995).","journal-title":"Vaccine"},{"key":"2209_CR11","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1016\/j.vaccine.2022.05.076","volume":"40","author":"CG Schneider","year":"2022","unstructured":"Schneider, C. G. et al. Norovirus-VLPs expressing pre-erythrocytic malaria antigens induce functional immunity against sporozoite infection. Vaccine 40, 4270\u20134280 (2022).","journal-title":"Vaccine"},{"key":"2209_CR12","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.2217\/nnm-2021-0250","volume":"16","author":"C Constantin","year":"2021","unstructured":"Constantin, C., Pisani, A., Bardi, G. & Neagu, M. Nano-carriers of COVID-19 vaccines: the main pillars of efficacy. Nanomedicine 16, 2377\u20132387 (2021).","journal-title":"Nanomedicine"},{"key":"2209_CR13","doi-asserted-by":"publisher","unstructured":"Maxmen, A. Scientists hail historic malaria vaccine approval\u2014but point to challenges ahead. Nature https:\/\/doi.org\/10.1038\/d41586-021-02755-5 (2021).","DOI":"10.1038\/d41586-021-02755-5"},{"key":"2209_CR14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","volume":"16","author":"MB Laurens","year":"2020","unstructured":"Laurens, M. B. RTS,S\/AS01 vaccine (Mxosquirix): an overview. Hum. Vaccin. Immunother. 16, 480\u2013489 (2020).","journal-title":"Hum. Vaccin. Immunother."},{"key":"2209_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4161\/hv.6.1.9677","volume":"6","author":"J Cohen","year":"2010","unstructured":"Cohen, J., Nussenzweig, V., Nussenzweig, R., Vekemans, J. & Leach, A. From the circumsporozoite protein to the RTS, S\/AS candidate vaccine. Hum. Vaccin. 6, 90\u201396 (2010).","journal-title":"Hum. Vaccin."},{"key":"2209_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"Rts, S. C. T. P.","year":"2015","unstructured":"Rts, S. C. T. P. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386, 31\u201345 (2015).","journal-title":"Lancet"},{"key":"2209_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1473-3099(13)70005-7","volume":"13","author":"P Bejon","year":"2013","unstructured":"Bejon, P. et al. Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data. Lancet Infect. Dis. 13, 319\u2013327 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"2209_CR18","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/S1473-3099(15)00239-X","volume":"15","author":"MT White","year":"2015","unstructured":"White, M. T. et al. Immunogenicity of the RTS,S\/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infect. Dis. 15, 1450\u20131458 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"2209_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0117-2","volume":"12","author":"MT White","year":"2014","unstructured":"White, M. T. et al. A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine. BMC Med. 12, 117 (2014).","journal-title":"BMC Med."},{"key":"2209_CR20","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","volume":"397","author":"MS Datoo","year":"2021","unstructured":"Datoo, M. S. et al. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. Lancet 397, 1809\u20131818 (2021).","journal-title":"Lancet"},{"key":"2209_CR21","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.4269\/ajtmh.22-0544a","volume":"107","author":"A Birkett","year":"2022","unstructured":"Birkett, A., Miller, R. S. & Soisson, L. A. The importance of exercising caution when comparing results from malaria vaccines administered on the EPI schedule and on a seasonal schedule. Am. J. Trop. Med. Hyg. 107, 1356 (2022).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"2209_CR22","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/j.1365-2958.2005.05024.x","volume":"59","author":"T Kariu","year":"2006","unstructured":"Kariu, T., Ishino, T., Yano, K., Chinzei, Y. & Yuda, M. CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts. Mol. Microbiol. 59, 1369\u20131379 (2006).","journal-title":"Mol. Microbiol."},{"key":"2209_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.meegid.2017.06.005","volume":"53","author":"AA Mehrizi","year":"2017","unstructured":"Mehrizi, A. A., Torabi, F., Zakeri, S. & Djadid, N. D. Limited genetic diversity in the global Plasmodium vivax cell traversal protein of ookinetes and sporozoites (CelTOS) sequences; implications for PvCelTOS-based vaccine development. Infect. Genet. Evol. 53, 239\u2013247 (2017).","journal-title":"Infect. Genet. Evol."},{"key":"2209_CR24","doi-asserted-by":"publisher","first-page":"e12294","DOI":"10.1371\/journal.pone.0012294","volume":"5","author":"ES Bergmann-Leitner","year":"2010","unstructured":"Bergmann-Leitner, E. S. et al. Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei. PLoS ONE 5, e12294 (2010).","journal-title":"PLoS ONE"},{"key":"2209_CR25","doi-asserted-by":"publisher","first-page":"9952","DOI":"10.1073\/pnas.1633254100","volume":"100","author":"DL Doolan","year":"2003","unstructured":"Doolan, D. L. et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc. Natl Acad. Sci. USA 100, 9952\u20139957 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2209_CR26","doi-asserted-by":"publisher","first-page":"102241","DOI":"10.1016\/j.jbc.2022.102241","volume":"298","author":"H Kumar","year":"2022","unstructured":"Kumar, H. et al. Implications of conformational flexibility, lipid binding, and regulatory domains in cell traversal-protein CelTOS for apicomplexan migration. J. Biol. Chem. 298, 102241 (2022).","journal-title":"J. Biol. Chem."},{"key":"2209_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51701-2","volume":"15","author":"WK Tang","year":"2024","unstructured":"Tang, W. K. et al. Multistage protective anti-CelTOS monoclonal antibodies with cross-species sterile protection against malaria. Nat. Commun. 15, 7487 (2024).","journal-title":"Nat. Commun."},{"key":"2209_CR28","doi-asserted-by":"publisher","first-page":"e20621","DOI":"10.7554\/eLife.20621","volume":"5","author":"JR Jimah","year":"2016","unstructured":"Jimah, J. R. et al. Malaria parasite CelTOS targets the inner leaflet of cell membranes for pore-dependent disruption. eLife 5, e20621 (2016).","journal-title":"eLife"},{"key":"2209_CR29","doi-asserted-by":"publisher","first-page":"e1007943","DOI":"10.1371\/journal.ppat.1007943","volume":"15","author":"H Kumar","year":"2019","unstructured":"Kumar, H. & Tolia, N. H. Getting in: the structural biology of malaria invasion. PLoS Pathog. 15, e1007943 (2019).","journal-title":"PLoS Pathog."},{"key":"2209_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102241","volume":"298","author":"H Kumar","year":"2022","unstructured":"Kumar, H. et al. Implications of conformational flexibility, lipid binding, and regulatory domains in cell-traversal protein CelTOS for apicomplexan migration. J. Biol. Chem. 298, 102241 (2022).","journal-title":"J. Biol. Chem."},{"key":"2209_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0169-4758(99)01592-6","volume":"16","author":"M Aidoo","year":"2000","unstructured":"Aidoo, M. & Udhayakumar, V. Field studies of cytotoxic T lymphocytes in malaria infections: implications for malaria vaccine development. Parasitol. Today 16, 50\u201356 (2000).","journal-title":"Parasitol. Today"},{"key":"2209_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/341323a0","volume":"341","author":"P Romero","year":"1989","unstructured":"Romero, P. et al. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341, 323\u2013326 (1989).","journal-title":"Nature"},{"key":"2209_CR33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.1211548","volume":"334","author":"JE Epstein","year":"2011","unstructured":"Epstein, J. E. et al. Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science 334, 475\u2013480 (2011).","journal-title":"Science"},{"key":"2209_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nm1009","volume":"10","author":"WHH Reece","year":"2004","unstructured":"Reece, W. H. H. et al. A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat. Med. 10, 406\u2013410 (2004).","journal-title":"Nat. Med."},{"key":"2209_CR35","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/81315","volume":"6","author":"SL Hoffman","year":"2000","unstructured":"Hoffman, S. L. & Doolan, D. L. Malaria vaccines-targeting infected hepatocytes. Nat. Med. 6, 1218\u20131219 (2000).","journal-title":"Nat. Med."},{"key":"2209_CR36","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.jmb.2007.09.038","volume":"374","author":"K Flicker","year":"2007","unstructured":"Flicker, K. et al. Structural and thermodynamic insights into the assembly of the heteromeric pyridoxal phosphate synthase from Plasmodium falciparum. J. Mol. Biol. 374, 732\u2013748 (2007).","journal-title":"J. Mol. Biol."},{"key":"2209_CR37","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1021\/bi602602x","volume":"46","author":"M Neuwirth","year":"2007","unstructured":"Neuwirth, M., Flicker, K., Strohmeier, M., Tews, I. & Macheroux, P. Thermodynamic characterization of the protein\u2013protein interaction in the heteromeric Bacillus subtilis pyridoxalphosphate synthase. Biochemistry 46, 5131\u20135139 (2007).","journal-title":"Biochemistry"},{"key":"2209_CR38","first-page":"1","volume":"3","author":"G Mittenhuber","year":"2001","unstructured":"Mittenhuber, G. Phylogenetic analyses and comparative genomics of vitamin B6 (pyridoxine) and pyridoxal phosphate biosynthesis pathways. J. Mol. Microbiol. Biotechnol. 3, 1\u201320 (2001).","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"2209_CR39","first-page":"1022","volume":"88","author":"VA Aleshin","year":"2023","unstructured":"Aleshin, V. A. & Bunik, V. I. Protein\u2013protein interfaces as druggable targets: a common motif of the pyridoxal-5\u2019-phosphate-dependent enzymes to receive the coenzyme from its producers. Biochemistry 88, 1022\u20131033 (2023).","journal-title":"Biochemistry"},{"key":"2209_CR40","doi-asserted-by":"publisher","first-page":"19284","DOI":"10.1073\/pnas.0604950103","volume":"103","author":"M Strohmeier","year":"2006","unstructured":"Strohmeier, M. et al. Structure of a bacterial pyridoxal 5\u2032-phosphate synthase complex. Proc. Natl Acad. Sci. USA 103, 19284\u201319289 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2209_CR41","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.str.2011.11.015","volume":"20","author":"G Guedez","year":"2012","unstructured":"Guedez, G. et al. Assembly of the eukaryotic PLP-synthase complex from Plasmodium and activation of the Pdx1 enzyme. Structure 20, 172\u2013184 (2012).","journal-title":"Structure"},{"key":"2209_CR42","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.1074\/jbc.M114.626382","volume":"290","author":"AM Smith","year":"2015","unstructured":"Smith, A. M., Brown, W. C., Harms, E. & Smith, J. L. Crystal structures capture three states in the catalytic cycle of a pyridoxal phosphate (PLP) synthase. J. Biol. Chem. 290, 5226\u20135239 (2015).","journal-title":"J. Biol. Chem."},{"key":"2209_CR43","doi-asserted-by":"publisher","first-page":"14609","DOI":"10.1021\/bi061464y","volume":"45","author":"F Zein","year":"2006","unstructured":"Zein, F. et al. Structural insights into the mechanism of the PLP synthase holoenzyme from Thermotoga maritima. Biochemistry 45, 14609\u201314620 (2006).","journal-title":"Biochemistry"},{"key":"2209_CR44","doi-asserted-by":"publisher","first-page":"E5821","DOI":"10.1073\/pnas.1608125113","volume":"113","author":"GC Robinson","year":"2016","unstructured":"Robinson, G. C., Kaufmann, M., Roux, C. & Fitzpatrick, T. B. Structural definition of the lysine swing in Arabidopsis thaliana PDX1: intermediate channeling facilitating vitamin B6 biosynthesis. Proc. Natl Acad. Sci. USA 113, E5821\u2013E5829 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2209_CR45","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1039\/D1CB00160D","volume":"3","author":"MJ Rodrigues","year":"2022","unstructured":"Rodrigues, M. J. et al. Trapping and structural characterisation of a covalent intermediate in vitamin B6 biosynthesis catalysed by the Pdx1 PLP synthase. RSC Chem. Biol. 3, 227\u2013230 (2022).","journal-title":"RSC Chem. Biol."},{"key":"2209_CR46","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1107\/S2059798319002912","volume":"75","author":"GC Robinson","year":"2019","unstructured":"Robinson, G. C. et al. Crystal structure of the pseudoenzyme PDX1.2 in complex with its cognate enzyme PDX1.3: a total eclipse. Acta Crystallogr. D 75, 400\u2013415 (2019).","journal-title":"Acta Crystallogr. D"},{"key":"2209_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21221-4","volume":"12","author":"T Pholcharee","year":"2021","unstructured":"Pholcharee, T. et al. Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum. Nat. Commun. 12, 1063 (2021).","journal-title":"Nat. Commun."},{"key":"2209_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84622-x","volume":"11","author":"MC Livingstone","year":"2021","unstructured":"Livingstone, M. C. et al. In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP). Sci. Rep. 11, 5318 (2021).","journal-title":"Sci. Rep."},{"key":"2209_CR49","doi-asserted-by":"publisher","first-page":"e0228177","DOI":"10.1371\/journal.pone.0228177","volume":"15","author":"KA Kusi","year":"2020","unstructured":"Kusi, K. A. et al. Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population. PLoS ONE 15, e0228177 (2020).","journal-title":"PLoS ONE"},{"key":"2209_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/21645515.2017.1381809","volume":"14","author":"P Moris","year":"2018","unstructured":"Moris, P., Jongert, E. & van der Most, R. G. Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine. Hum. Vaccin. Immunother. 14, 17\u201327 (2018).","journal-title":"Hum. Vaccin. Immunother."},{"key":"2209_CR51","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1207564","volume":"368","author":"A Olotu","year":"2013","unstructured":"Olotu, A. et al. Four-year efficacy of RTS,S\/AS01E and its interaction with malaria exposure. N. Engl. J. Med. 368, 1111\u20131120 (2013).","journal-title":"N. Engl. J. Med."},{"key":"2209_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau8529","volume":"4","author":"D Oyen","year":"2018","unstructured":"Oyen, D. et al. Cryo-EM structure of P. falciparum circumsporozoite protein with a vaccine-elicited antibody is stabilized by somatically mutated inter-Fab contacts. Sci. Adv. 4, eaau8529 (2018).","journal-title":"Sci. Adv."},{"key":"2209_CR53","doi-asserted-by":"publisher","first-page":"E10438","DOI":"10.1073\/pnas.1715812114","volume":"114","author":"D Oyen","year":"2017","unstructured":"Oyen, D. et al. Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein. Proc. Natl Acad. Sci. USA 114, E10438\u2013E10445 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2209_CR54","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.immuni.2017.11.007","volume":"47","author":"G Triller","year":"2017","unstructured":"Triller, G. et al. Natural parasite exposure induces protective human anti-malarial antibodies. Immunity 47, 1197\u20131209.e10 (2017).","journal-title":"Immunity"},{"key":"2209_CR55","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1073\/pnas.1911792117","volume":"117","author":"MD Langowski","year":"2020","unstructured":"Langowski, M. D. et al. Optimization of a Plasmodium falciparum circumsporozoite protein repeat vaccine using the tobacco mosaic virus platform. Proc. Natl Acad. Sci. USA 117, 3114\u20133122 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2209_CR56","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nm.4512","volume":"24","author":"NK Kisalu","year":"2018","unstructured":"Kisalu, N. K. et al. A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite. Nat. Med. 24, 408\u2013416 (2018).","journal-title":"Nat. Med."},{"key":"2209_CR57","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.immuni.2020.08.014","volume":"53","author":"LT Wang","year":"2020","unstructured":"Wang, L. T. et al. A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver. Immunity 53, 733\u2013744.e8 (2020).","journal-title":"Immunity"},{"key":"2209_CR58","doi-asserted-by":"publisher","first-page":"6860","DOI":"10.1128\/IAI.70.12.6860-6870.2002","volume":"70","author":"A Birkett","year":"2002","unstructured":"Birkett, A. et al. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts. Infect. Immun. 70, 6860\u20136870 (2002).","journal-title":"Infect. Immun."},{"key":"2209_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep19234","volume":"6","author":"KD Brune","year":"2016","unstructured":"Brune, K. D. et al. Plug-and-display: decoration of virus-like particles via isopeptide bonds for modular immunization. Sci. Rep. 6, 19234 (2016).","journal-title":"Sci. Rep."},{"key":"2209_CR60","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","volume":"12","author":"TUJ Bruun","year":"2018","unstructured":"Bruun, T. U. J., Andersson, A. C., Draper, S. J. & Howarth, M. Engineering a rugged nanoscaffold to enhance plug-and-display vaccination. ACS Nano 12, 8855\u20138866 (2018).","journal-title":"ACS Nano"},{"key":"2209_CR61","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2460749","volume":"21","author":"JM Hickey","year":"2025","unstructured":"Hickey, J. M. et al. PfCSP\u2013ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018(R) adjuvants: preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studies. Hum. Vaccin. Immunother. 21, 2460749 (2025).","journal-title":"Hum. Vaccin. Immunother."},{"key":"2209_CR62","doi-asserted-by":"publisher","first-page":"e48304","DOI":"10.1371\/journal.pone.0048304","volume":"7","author":"SA Kaba","year":"2012","unstructured":"Kaba, S. A. et al. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine. PLoS ONE 7, e48304 (2012).","journal-title":"PLoS ONE"},{"key":"2209_CR63","doi-asserted-by":"publisher","first-page":"e0142035","DOI":"10.1371\/journal.pone.0142035","volume":"10","author":"F Khan","year":"2015","unstructured":"Khan, F. et al. Head-to-head comparison of soluble vs. Qbeta VLP circumsporozoite protein vaccines reveals selective enhancement of NANP repeat responses. PLoS ONE 10, e0142035 (2015).","journal-title":"PLoS ONE"},{"key":"2209_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.641421","volume":"12","author":"L Kurtovic","year":"2021","unstructured":"Kurtovic, L. et al. Novel virus-like particle vaccine encoding the circumsporozoite protein of Plasmodium falciparum is immunogenic and induces functional antibody responses in mice. Front. Immunol. 12, 641421 (2021).","journal-title":"Front. Immunol."},{"key":"2209_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00653-7","volume":"8","author":"J Ludwig","year":"2023","unstructured":"Ludwig, J. et al. Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model. NPJ Vaccines 8, 52 (2023).","journal-title":"NPJ Vaccines"},{"key":"2209_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-12-136","volume":"12","author":"ME McCoy","year":"2013","unstructured":"McCoy, M. E. et al. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine. Malar. J. 12, 136 (2013).","journal-title":"Malar. J."},{"key":"2209_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-016-0181-1","volume":"14","author":"S Thrane","year":"2016","unstructured":"Thrane, S. et al. Bacterial superglue enables easy development of efficient virus-like particle based vaccines. J. Nanobiotechnology 14, 30 (2016).","journal-title":"J. Nanobiotechnology"},{"key":"2209_CR68","doi-asserted-by":"publisher","first-page":"e00090-17","DOI":"10.1128\/CVI.00090-17","volume":"24","author":"A Urakami","year":"2017","unstructured":"Urakami, A. et al. Development of a novel virus-like particle vaccine platform that mimics the immature form of alphavirus. Clin. Vaccine Immunol. 24, e00090-17 (2017).","journal-title":"Clin. Vaccine Immunol."},{"key":"2209_CR69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","volume":"95","author":"M Rojas","year":"2018","unstructured":"Rojas, M. et al. Molecular mimicry and autoimmunity. J. Autoimmun. 95, 100\u2013123 (2018).","journal-title":"J. Autoimmun."},{"key":"2209_CR70","doi-asserted-by":"crossref","unstructured":"Weiss, W. R., Sedegah, M., Beaudoin, R. L., Miller, L. H. & Good, M. F. CD8+ T cells (cytotoxic\/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl Acad. Sci. USA 85, 573\u2013576 (1988).","DOI":"10.1073\/pnas.85.2.573"},{"key":"2209_CR71","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.4049\/jimmunol.156.9.3374","volume":"156","author":"KL White","year":"1996","unstructured":"White, K. L., Snyder, H. L. & Krzych, U. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. J. Immunol. 156, 3374\u20133381 (1996).","journal-title":"J. Immunol."},{"key":"2209_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00819-x","volume":"9","author":"E Locke","year":"2024","unstructured":"Locke, E. et al. Establishing RTS,S\/AS01 as a benchmark for comparison to next-generation malaria vaccines in a mouse model. NPJ Vaccines 9, 29 (2024).","journal-title":"NPJ Vaccines"},{"key":"2209_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/srep46621","volume":"7","author":"KA Collins","year":"2017","unstructured":"Collins, K. A., Snaith, R., Cottingham, M. G., Gilbert, S. C. & Hill, A. V. S. Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine. Sci. Rep. 7, 46621 (2017).","journal-title":"Sci. Rep."},{"key":"2209_CR74","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.3390\/ijms21175971","volume":"21","author":"N Ullah","year":"2020","unstructured":"Ullah, N. et al. Solution structures and dynamic assembly of the 24-meric plasmodial Pdx1\u2013Pdx2 complex. Int. J. Mol. Sci. 21, 5971 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2209_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.688380","volume":"11","author":"ALC Barra","year":"2021","unstructured":"Barra, A. L. C. et al. Structural dynamics and perspectives of vitamin B6 biosynthesis enzymes in Plasmodium: advances and open questions. Front. Cell. Infect. Microbiol. 11, 688380 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"2209_CR76","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molbiopara.2006.12.005","volume":"152","author":"J Knockel","year":"2007","unstructured":"Knockel, J., Muller, I. B., Bergmann, B., Walter, R. D. & Wrenger, C. The apicomplexan parasite Toxoplasma gondii generates pyridoxal phosphate de novo. Mol. Biochem. Parasitol. 152, 108\u2013111 (2007).","journal-title":"Mol. Biochem. Parasitol."},{"key":"2209_CR77","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/j.1365-2958.2010.07381.x","volume":"78","author":"T Dick","year":"2010","unstructured":"Dick, T., Manjunatha, U., Kappes, B. & Gengenbacher, M. Vitamin B6 biosynthesis is essential for survival and virulence of Mycobacterium tuberculosis. Mol. Microbiol. 78, 980\u2013988 (2010).","journal-title":"Mol. Microbiol."},{"key":"2209_CR78","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"2209_CR79","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"2209_CR80","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1074\/jbc.M508696200","volume":"281","author":"M Gengenbacher","year":"2006","unstructured":"Gengenbacher, M. et al. Vitamin B6 biosynthesis by the malaria parasite Plasmodium falciparum: biochemical and structural insights. J. Biol. Chem. 281, 3633\u20133641 (2006).","journal-title":"J. Biol. Chem."},{"key":"2209_CR81","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"2209_CR82","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D"},{"key":"2209_CR83","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. D"},{"key":"2209_CR84","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/978-1-4939-2815-6_21","volume":"1325","author":"AM Salman","year":"2015","unstructured":"Salman, A. M. et al. Generation of transgenic rodent malaria parasites expressing human malaria parasite proteins. Methods Mol. Biol. 1325, 257\u2013286 (2015).","journal-title":"Methods Mol. Biol."},{"key":"2209_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17274-5","volume":"7","author":"A Rodriguez-Galan","year":"2017","unstructured":"Rodriguez-Galan, A. et al. An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens. Sci. Rep. 7, 17011 (2017).","journal-title":"Sci. Rep."},{"key":"2209_CR86","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.4269\/ajtmh.20-0183","volume":"103","author":"S Conteh","year":"2020","unstructured":"Conteh, S. et al. Dynamics and outcomes of Plasmodium infections in Grammomys surdaster (Grammomys dolichurus) thicket rats versus inbred mice. Am. J. Trop. Med. Hyg. 103, 1893\u20131901 (2020).","journal-title":"Am. J. Trop. Med. Hyg."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02209-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02209-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02209-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:01:51Z","timestamp":1767625311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-025-02209-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["2209"],"URL":"https:\/\/doi.org\/10.1038\/s41564-025-02209-y","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.H.T., D.S. and T.H.D. are listed inventors on patent application PCT\/US2025\/046419 related to this work. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}